Oxygen-sensitive T2* magnetic resonance imaging to correlate heart function and ischemic etiology of post-hospitalized chronic heart failure patients.


Journal

European journal of radiology
ISSN: 1872-7727
Titre abrégé: Eur J Radiol
Pays: Ireland
ID NLM: 8106411

Informations de publication

Date de publication:
Jul 2020
Historique:
received: 11 12 2019
revised: 24 03 2020
accepted: 22 04 2020
pubmed: 14 5 2020
medline: 8 1 2021
entrez: 14 5 2020
Statut: ppublish

Résumé

Myocardial oxygenation imaging is a field-of-interest but its clinical utility largely unexplored. We aimed to investigate the myocardial oxygenation status via T2* imaging and compared with the left ventricular ejection fraction (LVEF) in chronic heart failure (HF) patients after hospitalization. Also, we sought to compare the differences in myocardial oxygenation status among patients with ischemic HF, non-ischemic HF and controls. We prospectively enrolled 60 participants, comprising 20 HF patients with LVEF ≥ 50 % as the improved ejection fraction (HFIEF) group, 20 H F patients with ejection fraction <50 % as the reduced ejection fraction (HFREF) group, and 20 controls. Patients were also dichotomized into ischemic and non-ischemic subgroups. T2* values were compared across the study groups, and correlated with LVEF, myocardial scar distribution and quantity. T2* values positively correlated with LVEF and were significantly lower in the HFREF group as compared with both HFIEF and controls (20.06 vs. 24.23; 20.06 vs. 26.32, respectively, both p < 0.05). Lower T2* values were observed in the HFREF group than the HFIEF group and the ischemic subgroup than the non-ischemic subgroup. No significant correlation existed between T2* value and the myocardial scar amounts in ischemic territory. Oxygen-sensitive T2* measurements showed correlation with LVEF and ischemic etiology in chronic heart failure patients, while the ischemic HFREF patients appeared to be more vulnerable to myocardial oxygen reduction than other groups. T2* measurements may be clinically feasible in monitoring heart failure via myocardial oxygenation and lay the foundation for future studies in prediction heart failure recovery.

Identifiants

pubmed: 32403031
pii: S0720-048X(20)30225-4
doi: 10.1016/j.ejrad.2020.109036
pii:
doi:

Substances chimiques

Oxygen S88TT14065

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

109036

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None.

Auteurs

Yu-Hsiang Juan (YH)

Department of Medical Imaging and Intervention, Imaging Core Laboratory, Institute for Radiological Research, Chang Gung Memorial Hospital, Linkou and Chang Gung University, Taoyuan, 333, Taiwan; Department of Medical Imaging and Intervention, Chang Gung Memorial Hospital, Taoyuan and Chang Gung University, Taoyuan, 333, Taiwan; Clinical Metabolomics Core Laboratory, Chang Gung Memorial Hospital at Linkou, Taoyuan, 333, Taiwan.

Pei-Ching Huang (PC)

Department of Medical Imaging and Intervention, Imaging Core Laboratory, Institute for Radiological Research, Chang Gung Memorial Hospital, Linkou and Chang Gung University, Taoyuan, 333, Taiwan.

Gigin Lin (G)

Department of Medical Imaging and Intervention, Imaging Core Laboratory, Institute for Radiological Research, Chang Gung Memorial Hospital, Linkou and Chang Gung University, Taoyuan, 333, Taiwan; Clinical Metabolomics Core Laboratory, Chang Gung Memorial Hospital at Linkou, Taoyuan, 333, Taiwan.

Min-Hui Liu (MH)

Heart Failure Research Center, Division of Cardiology, Department of Internal Medicine, Chang Gung Memorial Hospital, Keelung and Chang Gung University College of Medicine, Taoyuan, 20401, Taiwan; Department of Nursing, National Yang-Ming University, Taipei, 11221, Taiwan.

Yu-Ching Lin (YC)

Department of Medical Imaging and Intervention, Imaging Core Laboratory, Institute for Radiological Research, Chang Gung Memorial Hospital, Linkou and Chang Gung University, Taoyuan, 333, Taiwan; Department of Medical Imaging and Intervention, Chang Gung Memorial Hospital, Keelung and Chang Gung University, 20401, Taiwan.

Jiun-Jie Wang (JJ)

Department of Medical Imaging and Intervention, Imaging Core Laboratory, Institute for Radiological Research, Chang Gung Memorial Hospital, Linkou and Chang Gung University, Taoyuan, 333, Taiwan.

Koon-Kwan Ng (KK)

Department of Medical Imaging and Intervention, Chang Gung Memorial Hospital, Keelung and Chang Gung University, 20401, Taiwan.

Yun-Chung Cheung (YC)

Department of Medical Imaging and Intervention, Imaging Core Laboratory, Institute for Radiological Research, Chang Gung Memorial Hospital, Linkou and Chang Gung University, Taoyuan, 333, Taiwan.

Chao-Hung Wang (CH)

Heart Failure Research Center, Division of Cardiology, Department of Internal Medicine, Chang Gung Memorial Hospital, Keelung and Chang Gung University College of Medicine, Taoyuan, 20401, Taiwan. Electronic address: bearty54@adm.cgmh.org.tw.

Shu-Hang Ng (SH)

Department of Medical Imaging and Intervention, Imaging Core Laboratory, Institute for Radiological Research, Chang Gung Memorial Hospital, Linkou and Chang Gung University, Taoyuan, 333, Taiwan. Electronic address: shuhangng@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH